Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
ID: 358024Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358024

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-324.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Method to Extend Research in Time (MERIT) Award Extension, aimed at providing extended grant support to Early Stage Investigators (ESIs) who have shown strong research potential and received favorable evaluations on their R01 applications. This funding opportunity allows for up to seven years of support in two segments, enabling ESIs to establish their careers while focusing on critical cancer research areas such as identifying cancer risks, improving early detection strategies, and developing treatment methods. Interested applicants, including a diverse range of institutions such as Historically Black Colleges and Universities and Tribal Colleges, must adhere to specific application guidelines and register with Grants.gov and eRA Commons, with applications opening on February 3, 2025, and due by March 3, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-324-Full-Announcement.html
    PAR-25-324.html
    The National Cancer Institute (NCI) is issuing a funding opportunity through the Method to Extend Research in Time (MERIT) Award Extension. This initiative aims to provide extended grant support to Early Stage Investigators (ESIs) who have demonstrated strong research potential and have received favorable evaluations on their R01 applications. The program allows for two segments of funding up to seven years, assisting ESIs in establishing their careers without the immediate pressure of renewal applications. The funding goals focus on identifying cancer risks, improving early detection strategies, developing cancer treatment methods, and advancing cancer biology research. Key dates include the opening date for applications on February 3, 2025, with applications due by March 3, 2025. Eligible applicants encompass a wide range of institutions, including schools and non-profits. The application process necessitates adherence to specific guidelines and registrations with systems like Grants.gov and eRA Commons. The review of applications will be administrative, focusing on the justification of extensions and the significance of the proposed research. This funding opportunity reflects a commitment to fostering innovative cancer research that ultimately aims to reduce cancer incidence and improve patient outcomes.
    Similar Opportunities
    Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESIs), aimed at supporting fundamental, investigator-initiated research within the mission of the National Institute of General Medical Sciences (NIGMS). This grant program is designed to provide funding stability and scientific flexibility, allowing early career researchers to undertake ambitious studies while reducing administrative burdens by consolidating all NIGMS research support into a single award. The MIRA program is crucial for enhancing scientific productivity and fostering breakthroughs in health research, with no cost-sharing or matching requirements. Interested applicants can reach out to Michelle R. Bond, Ph.D. and Marc Rigas, Ph.D. at 301-594-2987 or via email at ESIMIRA@nigms.nih.gov for further information. The estimated project start date is July 1, 2027, with applications expected to close on October 5, 2026.
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions, specifically in the field of cancer research. This program provides a structured funding mechanism over five years, consisting of a two-year mentored training phase (K99) followed by a three-year independent research phase (R00), with a focus on proposals that align with the NCI's mission. Eligible applicants include a diverse range of institutions, such as historically black colleges and universities, Hispanic-serving institutions, and other nonprofit entities, although candidates must not hold independent research faculty positions and should have no more than six years of postdoctoral experience. Interested applicants can find more information and submit their proposals starting January 27, 2025, with the application deadline set for October 14, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) to provide stable and flexible funding support for individual investigators aligned with the scientific mission of the National Institute of General Medical Sciences (NIGMS). This grant aims to enhance funding stability, foster innovative research projects, and reduce administrative burdens, allowing researchers to focus more on their scientific endeavors and mentorship of junior scientists. Eligible applicants include NIGMS-funded investigators and New Investigators, with specific guidelines for Early-Stage Investigators to apply through a separate notice of funding opportunity (NOFO). The application deadline is May 26, 2028, and interested parties can reach out to NIGMS at NIGMSEINIMIRA@nigms.nih.gov for further information. The typical budget for New Investigator MIRA grants is set at $275,000 annually in direct costs.
    NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Supporting Talented Early Career Researchers in Genomics," aimed at supporting innovative research projects led by Early Stage Investigators (ESIs) with a focus on genomics. This initiative encourages diverse applicants to propose research that aligns with the mission of the National Human Genome Research Institute (NHGRI), covering areas such as genomic sciences, genomic medicine, genomic data science, and the ethical implications of genomics. The program has a funding commitment of at least $2 million, with plans to award 3-5 grants, each with an annual budget cap of $400,000. Applications must be submitted electronically by February 26, 2027, and should include a detailed professional development plan and a resource sharing plan in compliance with NIH policies. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators' Research Award
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (MIRA), a federal grant aimed at supporting research within the mission of the National Institute of General Medical Sciences (NIGMS). This grant is designed to provide funding stability and scientific flexibility to eligible small businesses and NIGMS-funded investigators, thereby fostering innovative research and enhancing scientific productivity. The MIRA program has become a primary mechanism for supporting fundamental, investigator-initiated research, and encourages applications from both established and new investigators. Interested applicants can reach out to Baishali Maskeri, Ph.D., and Charles Ashley Barnes, Ph.D., at NIGMSEINIMIRA@NIGMS.NIH.GOV or by phone at 301-594-2752. The estimated synopsis close date is January 27, 2026, with awards expected to be made by December 1, 2026.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed), aimed at supporting innovative research projects that signify a new direction for early stage investigators (ESIs). Applicants must propose projects without any preliminary data and align their research with the mission of participating NIH Institutes and Centers, while clinical trials are explicitly prohibited. This grant initiative is crucial for fostering innovation among ESIs, allowing them to explore novel research avenues over a maximum project period of five years. Interested applicants should note that the first application deadline is August 25, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Stephen I. Katz Early Stage Investigator Research Project Grant (R01), aimed at supporting early stage investigators (ESIs) in initiating research projects that diverge from their previous focus. Applicants must propose innovative research directions that do not build upon prior work, encouraging a shift in methodology, discipline, or therapeutic target, and are advised to consult with program directors regarding their proposals. This grant is crucial for fostering new scientific inquiries and advancing health-related research, with no cost-sharing requirements and an estimated award date of July 1, 2026. Interested applicants can reach out to the Division of Biomedical Research Workforce at NIH via email at nihtrain@mail.nih.gov or by phone at 301-496-0180 for further information, with applications expected to be submitted by September 26, 2025.